Golimumab

ERGIC3 (Endoplasmic reticulum-Golgi intermediate compartment protein 3) is a membrane protein that shuttles between the Golgi apparatus and the endoplasmic reticulum (ER). It has large domains which face the ER lumen, and the small N- and C-termini

Anti-GAB3 GRB2-associated binding protein 3, 25ul UN 1687 6.

The gene GOLGA2 (golgin subfamily A member 2) is mapped to human chromosome 9q34.11.

The gene GOLGA2 (golgin subfamily A member 2) is mapped to human chromosome 9q34.11.

Immunogen Synthetic peptide directed towards the N terminal region of human GOLGB1 Biochem/physiol Actions GOLGB1 may participate in forming intercisternal cross-bridges of the Golgi complex. Sequence Synthetic peptide located within the

Anti-GOLIM4 golgi integral membrane protein 4, 100ul UN 1687

Anti-GOLIM4 golgi integral membrane protein 4, 100ul UN 1687

Golimumab with trade name Simponi, is an FDA-approved drug for the treatment of Rheumatoid arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) and Ulcerative Colitis (UC). It is a human IgG1&kappa monoclonal antibody that binds

GOLM1 (golgi membrane protein 1) gene is localized to human chromosome 9q21.33 and is expressed normal epithelial cells of tissues, such as the gut, prostate, kidneys, lungs and within the central nervous system.

GOLM1 (Golgi membrane protein 1) is a resident, type II, 73kDa, Golgi-localized integral membrane protein consisting of an N-terminal transmembrane domain and a coiled-coil domain at the C-terminal luminal surface of the Golgi apparatus. It is

The gene GOPC (Golgi-associated PDZ and coiled-coil motif-containing protein) is mapped to human chromosome 6q22.1.

Golgi SNAP receptor complex member 1 (GOSR1) has a molecular weight of 28kDa. It is part of the Golgi-soluble N -ethylmaleimide-sensitive fusion protein-attachment protein receptor complex (SNARE).